🔗 Share this article

An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Treatment Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of next-day UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Material Removal

Based on the social media company, the service has removed problematic material and prohibited associated keywords and query recommendations. The organization said it was committed to keeping the service safe and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Investigations also found groups with up to nine thousand participants marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of slimming results, glowing reviews and detailed guides for preparing or injecting at home.

Within minutes of entering one group, a seller shared WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.

Item Information and Costs

Inside these communities, messages display black plastic parcels with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram said it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to possibly significant health risks”.